NCT03904706

Brief Summary

Pakistan is one of the countries in South Asia where neonatal mortality rates remain stagnant. Babies born in Pakistan encounter the highest risk of dying; of every 1,000 babies born, 46 die before the end of their first month (UNICEF, 2018). Some of the highest perinatal and neonatal mortality rates in Pakistan are found in districts of Pakistan's mountainous northern region (Bhutta ZA, 2013), where geography, climate and security risks make it challenging for women in remote communities to reach health services in a timely manner. According to 2013 PDHS, the neonatal and perinatal mortality rate in the northern area of Gilgit Baltistan was 39/1,000 and 37/1,000, respectively. In the rural area of Khyber Pakhtunkhwa, the neonatal and perinatal mortality rate was 42/1,000 and 63/1,000, respectively. Implementation of a health facility mortality audit cycle has proved successful in reducing perinatal mortality by upto 30% in other LMICs. Meanwhile evidence suggests that the most common factors contributing to high mortality rates are due to phase-one delays (delay in the decision to seek care). This study will attempt to operationalize linkages between the community and facility to not only improve facility-based quality of care, but to bring change in the community through community-feedback meetings to mitigate phase one and two delays and improve maternal, perinatal and neonatal outcomes. Data from this study will inform MoH policy decisions about standardized mortality audits with community feedback. Given the geographical location of Gilgit-Baltistan (GB) and accompanying constraints such as terrain and security, this study will attempt to operationalize linkages between the community and facility to not only improve facility-based quality of care, but to bring change in the community through community-feedback meetings to mitigate phase one and two delays and improve maternal, perinatal and neonatal outcomes. Data from this study will inform MoH policy decisions about standardized mortality audits with community feedback.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,871

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2019

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 4, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 5, 2019

Completed
11 days until next milestone

Study Start

First participant enrolled

April 16, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2020

Completed
Last Updated

July 10, 2020

Status Verified

July 1, 2020

Enrollment Period

11 months

First QC Date

April 4, 2019

Last Update Submit

July 8, 2020

Conditions

Keywords

Facility-basedMortalityAuditsCommunity engagementGilgit-BaltistanPakistan

Outcome Measures

Primary Outcomes (2)

  • Change in proportion of women who can correctly identify at least 3 danger signs at each stage across the continuum of care

    Change in proportion of women who can correctly identify at least 3 danger signs at each stage across the continuum of care

    12 months

  • Change in proportion of women for which at least 5 birthing plan actions were taken for the birth of the index child

    Change in proportion of women for which at least 5 birthing plan actions were taken for the birth of the index child: Discussed place of delivery, Discussed who will perform delivery, Set aside funds for delivery, Set aside alternate funds for costs of skilled and emergency care, Made arrangements for transport, Identified a blood donor, Discussed accompaniment to planned delivery location.

    12 months

Secondary Outcomes (6)

  • Change in number of facility deliveries

    12 months

  • Change in severe maternal morbidity outcomes

    12 months

  • Change in the quality of delivery services

    12 months

  • Change in proportion of first, second and third delays

    12 months

  • Perinatal mortality (fresh stillbirth or neonatal death in the first week of life)

    12 months

  • +1 more secondary outcomes

Study Arms (3)

Audits only

EXPERIMENTAL

Formalized audit teams with monthly meetings at each facility. Audit Intervention phases: 1. Identification of facility leadership (i.e physicians or leading health care providers) to be trained on best practices in obstetric and perinatal care in the implementation of the audits. 2. Training of identified audit leaders (main investigator is typically a physician) a. 5-day training workshop to include: i. Day 1: maternal death and near misses, perinatal, neonatal deaths and morbidity outcomes ii. Day 2: 'Three-delay' framework and identifying modifiable factors iii. Day 3: data collection and setting up the audit system iv. Days 4-5: mentoring on the identification of the audit teams and initiating audit implementation 3. Creating audit team (composed of at least two obstetricians, 2 pediatricians plus the main investigator) 4. Establishing and launching the audit cycle (monthly meetings) 5. Annual re-certification of audit leaders

Other: Audits only

Audits with community feedback

EXPERIMENTAL

This intervention will implement the audits as described in arm 1; however, key community representatives (approximately 3-5 members) will be identified to attend monthly follow-up meetings with audit team leaders to discuss the community aspects (phase one and two-delays) that could have prevented the death, near miss or severe adverse outcome. Information regarding the cause(s) of death in the community will be collected by the LHW or CMW, who reports to the health facility on a monthly basis.

Other: Audits with community feedback

Control

NO INTERVENTION

Monthly outcome data will be collected from health facilities where no audits will be conducted. Data from this group will help evaluate the effectiveness of the intervention arms on perinatal and neonatal mortality.

Interventions

Formalized audit teams with monthly meetings at each facility.

Audits only

This intervention will implement the audits as described in arm 1; however, key community representatives (approximately 3-5 members) will be identified to attend monthly follow-up meetings with audit team leaders to discuss the community aspects (phase one and two-delays) that could have prevented the death, near miss or severe adverse outcome. Information regarding the cause(s) of death in the community will be collected by the LHW or CMW, who reports to the health facility on a monthly basis.

Audits with community feedback

Eligibility Criteria

Age15 Years - 49 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Women aged 15-49 years who have had a pregnancy in the last 12 months who reside in the five targeted districts. Public and private health facilities in five districts in GB that offer obstetric and postnatal care, and respective catchment areas are supported by LHWs, Lady Health Volunteers (LHVs), CMWs, and CHWs will be included in the study. Data for all maternal 'near misses', perinatal and neonatal mortality and morbidity outcomes will be recorded for all women and newborns who deliver at home (through LHW, LHV, CMW monthly reports) and who contact the health facility within 42 days post-delivery, regardless of whether or not they delivered in the health facility.

You may not qualify if:

  • Women aged 15-49 years who have not had a pregnancy in the last 12 months, who reside in the five targeted districts. Health facilities in five districts of GB that do not provide any obstetric and postnatal care and are not affiliated with any LHWs, or CMWs will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Government and AKHSP Health Facilities in Gilgit-Baltistan

Gilgit, Astore, Ghizer, Hunza and Nagar, Gilgit-Baltistan, 74800, Pakistan

Location

MeSH Terms

Conditions

StillbirthPerinatal Death

Condition Hierarchy (Ancestors)

Fetal DeathPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Sajid Soofi, FCPS, MBBS

    Aga Khan University

    PRINCIPAL INVESTIGATOR
  • Diego Bassani, PhD

    Centre for Global Child Health, SickKids Research Institute - Toronto, Canada

    PRINCIPAL INVESTIGATOR
  • Aminah Jahangir, MBBS, HPM

    Aga Khan Foundation, Pakistan

    PRINCIPAL INVESTIGATOR
  • Zulfiqar A Bhutta, PhD

    Centre for Global Child Health, SickKids Research Institute - Toronto, Canada

    PRINCIPAL INVESTIGATOR
  • Gul Nawaz Khan, MA, MPH

    Aga Khan University

    PRINCIPAL INVESTIGATOR
  • Suzanne E Powell, MSc

    Centre for Global Child Health, SickKids Research Institute - Toronto, Canada

    PRINCIPAL INVESTIGATOR
  • Miraj Uddin, MA

    Aga Khan Health Services

    PRINCIPAL INVESTIGATOR
  • Saad Y Sulaimani, MSc

    Aga Khan Foundation, Pakistan

    PRINCIPAL INVESTIGATOR
  • Asma Sittar, MSc

    Aga Khan Development Network - Islamabad, Pakistan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Health facilities (clusters) will be the units of randomization. Within each stratum, health facilities will be randomly allocated to one of the three arms. Arm 1: includes morbidity and mortality health facility audits-only; arm 2: includes morbidity and mortality health facility audits in addition to community-engagement; and arm 3: will serve as the control arm and collect outcome data only.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: This will be a three-arm cluster randomized controlled study to evaluate a novel intervention. Each facility is a cluster and includes all deliveries (including stillbirths and live births) in health facilities and respective catchment areas that provide obstetric and post-natal services.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 4, 2019

First Posted

April 5, 2019

Study Start

April 16, 2019

Primary Completion

March 20, 2020

Study Completion

May 31, 2020

Last Updated

July 10, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations